WONDERCEL THERAPEUTICS
DEAD

Serial Number

79417405

Owner

Shenzhen Wandao Cell Technology Co., Ltd.

Filing Date

Oct 23, 2024

Add to watchlist:

No watchlists yet
View on USPTO

WONDERCEL THERAPEUTICS Trademark

Serial Number: 79417405

WONDERCEL THERAPEUTICS is a trademark filed by Shenzhen Wandao Cell Technology Co., Ltd. on October 23, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Shenzhen Wandao Cell Technology Co., Ltd.

Room 301, Building 6, North District,

Entity Type: 98

Trademark Details

Filing Date

October 23, 2024

Registration Date

Not Registered

Goods & Services

Health care; medical assistance; medical clinic services; nutritional therapy services; massage therapy services; stem cell therapy services; music therapy services; meditation therapy services; animal-assisted therapy; pharmacists' services to make up prescriptions; medical screening; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; nursing, medical; telemedicine services; hospital services

Culturing of cells for others for scientific research purposes; medical and scientific research, namely, conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others; development of pharmaceutical preparations and medicines; scientific research in the field of genetics; pharmaceutical research services; pharmaceutical research and development; scientific research for medical purposes in the area of cancerous diseases

Living cells for medical use; pharmaceutical products for the prevention and treatment of cancer; anti-cancer preparations; cardiovascular pharmaceutical preparations; effervescent analgesic pharmaceutical preparations; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; biological preparations for the treatment of cancer; vaccine preparations; reagents for medical use; cells for medical use; pharmaceutical preparations for the treatment of immune system related diseases and disorders; tumor suppressing agents; pharmaceutical products for the treatment of cancer; medical diagnostic reagents; cytostatics for medical purposes; stem cells for medical purposes

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 20, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 19, 2026 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jun 25, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 25, 2026 ABN2
REFUSAL PROCESSED BY IB
Dec 25, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 11, 2025 RFCS
REFUSAL PROCESSED BY MPU
Dec 11, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 5, 2025 RFCR
NON-FINAL ACTION WRITTEN
Nov 4, 2025 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Oct 29, 2025 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 12, 2025 RFCR
NON-FINAL ACTION WRITTEN
Sep 11, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 11, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 10, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 10, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 13, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 20, 2025 REPR